Gluten‑free Market Driven by Psychosomatic Label

Although many consumers and restaurants treat 'non‑celiac gluten sensitivity' as a medical condition, the clinical challenge trials and reviews suggest symptoms attributed to gluten often trace to gut‑brain interaction (psychosomatic) disorders rather than a clear gluten intolerance. The result is a booming gluten‑free market that may be responding to a self‑diagnosed or socially mediated syndrome more than a validated biological disease. — If true, this reframes food‑industry growth, dietary guidance, and clinical practice and calls for stricter evidence standards before medicalizing lifestyle products.